Foreign Drug Inspection Program
2008-04-29T21:20:00-04:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvODEwXC8yMDUwOTMtbS5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==A hearing was held on the circumstances surrounding the contamination of heparin imported from China.
According to the FDA, 81 people have died after allergic reactions to the
anticoagulant drug heparin since January 2007. Family members of victims who died after being treated with heparin testified. Dr. Woodcock testified
that with outsourcing of drug production to countries such as India and
China, the FDA is not currently configured to regulate global markets, and the
FDA’s inspection coverage is underfunded. Representative from two
companies responsible for introducing the contaminated heparin into the
U.S. also testified.
Witnesses responded to questions from committee members.
According to the FDA, 81 people have died after allergic reactions to the
anticoagulant drug heparin since January 2007. Family members of victims who died after being treated with heparin testified. Dr. Woodcock testified
that with outsourcing of drug production to countries such as India and
China, the FDA is not currently configured to regulate global markets, and the
FDA’s inspection coverage is underfunded. Representative from two
companies responsible for introducing the contaminated heparin into the
U.S. also testified.
Witnesses responded to questions from committee members.
A hearing was held on the circumstances surrounding the contamination of heparin imported from China. According to the FDA, 81 people hav… read more
A hearing was held on the circumstances surrounding the contamination of heparin imported from China.
According to the FDA, 81 people have died after allergic reactions to the
anticoagulant drug heparin since January 2007. Family members of victims who died after being treated with heparin testified. Dr. Woodcock testified
that with outsourcing of drug production to countries such as India and
China, the FDA is not currently configured to regulate global markets, and the
FDA’s inspection coverage is underfunded. Representative from two
companies responsible for introducing the contaminated heparin into the
U.S. also testified.
Witnesses responded to questions from committee members. close
People in this video
-
Deborah M. Autor Compliance Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research -
-
-
Leroy Hubley Spouse
-
-
-
Johanna Marie Staples Spouse
-
-
-
Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
-
-
-
-
-
-
-
Hosting Organization
Purchase a Download
Foreign Drug Inspection Program
-
MP4 video - Standard
- Price:
- $9.99
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
Foreign Drug Inspection
Witnesses testified about safety inspections by U.S. government officials of foreign drug imports. They focused on a lac…
-
Foreign Drugs Safety and Inspection
Rep. Bart Stupak talked about safety and inspection of foreign drugs coming in the U.S. and a committee hearing he wil…
-
Earthquake in China
Chinese Embassy Press Counsellor Wang Baodong spoke to the press about the latest developments on the recent earthquake …
-
Presidential Trip to China
China Central Television showed coverage of President Obama’s trip to Beijing. The program included his meeting with Chi…
User Created Clips from This Video
-
- 4 minutes
- 79 views
-
- 12 minutes
- 17 views
-
- 3 minutes
- 11 views
-
- 15 seconds
- 10 views